Ampleia is a venture-building organization dedicated to support rare diseases therapeutics projects. We work with exceptional scientists and entrepreneurs developing therapeutic options for under-served indications. We act as an operating co-founder from day 1, bringing funding, translational development capabilities and corporate support. We are from each decision to prepare the founders and the company to Series A or strategic deal. We adopt a technology-agnostic approach and work on projects from anywhere in the world.
| Website | https://www.ampleia.eu |
| Employees | 5 (4 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Venture Building, Rare Disease Research, Therapeutic Options, Drug Discovery, Drug Development, Clinical Development, Clinical Trials, Pharmaceutical Development, Biotech, Pharmaceutical, Life Sciences, Biotechnology, Medical Research, Venture Capital, Health Tech |
| Competitors | Haivision, Wowza, Bitmovin, Avid, Brightcove, Zixi, Telestream, Encoding.com, Mediaproxy Pty Ltd +46 more (view full list) |
Looking for a particular Ampleia employee's phone or email?
Ampleia Questions
Pierre-Albert Colcomb is the COO of Ampleia.
4 people are employed at Ampleia.
Top Ampleia Employees
-
22
-
5+5+
-
Alexandre Lemoalle
Président at Ampleia
Pornic, FR31
Related Companies
